PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
It’s raining biopharma execs
Read Original Article: PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama »
